• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRASCORE FOCUSED FORCE PTA BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRASCORE FOCUSED FORCE PTA BALLOON Back to Search Results
Model Number US35130520
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Stenosis (2263); Vascular Dissection (3160)
Date of Event 04/08/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lot number for the device was provided.The device history records are currently under review.The device was not returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiration date: 06/2020).
 
Event or Problem Description
It was reported through the results of a clinical trial, that approximately 7-month post angioplasty procedure with a focused force percutaneous transluminal angioplasty (pta) balloon dilatation catheter, stenosis was identified in the superficial femoral artery.It was further reported revascularization was performed using pta balloon.
 
Additional Manufacturer Narrative
Manufacturing review: a lot history review was conducted and it was determined that a device history record (dhr) review was not required.Investigation summary: the investigation is inconclusive, as no objective evidence has been provided to confirm any alleged deficiency with the device.Based upon the available information, the definitive root cause is unknown.Label review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.
 
Event or Problem Description
It was reported through the results of a clinical trial, that approximately 7-month post angioplasty procedure with a focused force percutaneous transluminal angioplasty (pta) balloon dilatation catheter, stenosis was identified in the superficial femoral artery.It was further reported revascularization was performed using pta balloon.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRASCORE FOCUSED FORCE PTA BALLOON
Common Device Name
FOCUSED FORCE PTA BALLOON
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key8689001
Report Number2020394-2019-00962
Device Sequence Number3030512
Product Code PNO
UDI-Device Identifier00801741116803
UDI-Public(01)00801741116803
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K163420
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberUS35130520
Device Catalogue NumberUS35130520
Device Lot NumberGFCR3320
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/15/2019
Supplement Date Received by Manufacturer09/06/2019
Initial Report FDA Received Date06/11/2019
Supplement Report FDA Received Date09/13/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ASPIRIN; ASPIRIN; CLOPIDOGREL; CLOPIDOGREL
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
-
-